ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
2.590
+0.400 (18.26%)
At close: Jun 27, 2025, 4:00 PM
2.600
+0.010 (0.38%)
After-hours: Jun 27, 2025, 7:42 PM EDT
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $42.09 million as of June 27, 2025. Its market cap has increased by 383.79% in one year.
Market Cap
42.09M
Enterprise Value
44.75M
1-Year Change
383.79%
Ranking
Category
Stock Price
$2.59
Market Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $42.09M, a decrease of -47.06%. That is a compound annual growth rate of -15.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 36.70M | 376.62% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |